AU Patent

AU2006289281A1 — Pyridine derivatives and their use in the treatment of psychotic disorders

Assigned to Kandy Therapeutics Ltd · Expires 2007-03-15 · 19y expired

What this patent protects

Patent listed against elinzanetant.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006289281A1
Jurisdiction
AU
Classification
—
Expires
2007-03-15
Drug substance claim
No
Drug product claim
No
Assignee
Kandy Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.